Patents by Inventor Kip Dudgeon

Kip Dudgeon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Modified variable domain molecules and methods for producing them
    Patent number: 11332522
    Abstract: The present disclosure provides an isolated, engineered or non-naturally occurring protein comprising an antibody light chain variable domain (VL) which may comprise at least one negatively charged amino acid positioned between residues 49 to 56 according to the numbering system of Kabat, the protein capable of binding specifically to an antigen.
    Type: Grant
    Filed: May 9, 2019
    Date of Patent: May 17, 2022
    Assignee: GARVAN INSTITUTE OF MEDICAL RESEARCH
    Inventors: Daniel Christ, Kip Dudgeon, Romain Rouet
  • MODIFIED VARIABLE DOMAIN MOLECULES AND METHODS FOR PRODUCING THEM
    Publication number: 20200102376
    Abstract: The present disclosure provides an isolated, engineered or non-naturally occurring protein comprising an antibody light chain variable domain (VL) which may comprise at least one negatively charged amino acid positioned between residues 49 to 56 according to the numbering system of Kabat, the protein capable of binding specifically to an antigen.
    Type: Application
    Filed: May 9, 2019
    Publication date: April 2, 2020
    Inventors: Daniel Christ, Kip Dudgeon, Romain Rouet
  • MODIFIED VARIABLE DOMAIN MOLECULES AND METHODS FOR PRODUCING THEM
    Publication number: 20170240619
    Abstract: The present disclosure provides an isolated, engineered or non-naturally occurring protein comprising an antibody light chain variable domain (VL) which may comprise at least one negatively charged amino acid positioned between residues 49 to 56 according to the numbering system of Kabat, the protein capable of binding specifically to an antigen.
    Type: Application
    Filed: November 7, 2016
    Publication date: August 24, 2017
    Inventors: Daniel Christ, Kip Dudgeon, Romain Rouet
  • Modified variable domain molecules and methods for producing them
    Patent number: 9527908
    Abstract: The present disclosure provides an isolated, engineered or non-naturally occurring protein comprising an antibody light chain variable domain (VL) which may comprise at least one negatively charged amino acid positioned between residues 49 to 56 according to the numbering system of Kabat, the protein capable of binding specifically to an antigen.
    Type: Grant
    Filed: October 15, 2013
    Date of Patent: December 27, 2016
    Assignee: GARVAN INSTITUTE OF MEDICAL RESEARCH
    Inventors: Daniel Christ, Kip Dudgeon, Romain Rouet
  • Modified Variable Domain Molecules And Methods For Producing And Using Same
    Publication number: 20160145328
    Abstract: The present disclosure provides an isolated protein comprising an antibody heavy chain variable region (VH) comprising a negatively charged amino acid at position 28 and/or 31 and/or 32 and/or 33 and/or 35 according to the numbering system of Kabat, the protein capable of binding specifically to an antigen.
    Type: Application
    Filed: October 21, 2015
    Publication date: May 26, 2016
    Inventors: Daniel Christ, Kip Dudgeon
  • MODIFIED VARIABLE DOMAIN MOLECULES AND METHODS FOR PRODUCING THEM B
    Publication number: 20140234218
    Abstract: The present disclosure provides an isolated, engineered or non-naturally occurring protein comprising an antibody light chain variable domain (VL) which may comprise at least one negatively charged amino acid positioned between residues 49 to 56 according to the numbering system of Kabat, the protein capable of binding specifically to an antigen.
    Type: Application
    Filed: October 15, 2013
    Publication date: August 21, 2014
    Applicant: GARVAN INSTITUTE OF MEDICAL RESEARCH
    Inventors: Daniel Christ, Kip Dudgeon, Romain Rouet
  • Modified Variable Domain Molecules And Methods For Producing And Using Same
    Publication number: 20120207673
    Abstract: The present disclosure provides an isolated protein comprising an antibody heavy chain variable region (VH) comprising a negatively charged amino acid at position 28 and/or 31 and/or 32 and/or 33 and/or 35 according to the numbering system of Kabat, the protein capable of binding specifically to an antigen.
    Type: Application
    Filed: October 25, 2010
    Publication date: August 16, 2012
    Inventors: Daniel Christ, Kip Dudgeon